KeyBank National Association
BLUE

KeyBank National Association’s bluebird bio BLUE Stock Holding History

KeyBank National Association’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-512
Closed -$65K – 1062
2022
Q3 		$65K Hold
512
– – ﹤0.01% 1023
2022
Q2 		$42K Buy
+512
New +$39.7K ﹤0.01% 1054

Other funds holding BLUE

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

KeyBank National Association's BLUE Position: Q4 2022 in Review

KeyBank National Association sold out of bluebird bio (BLUE) in Q4 2022, closing a stake of 512 shares — an estimated $65K sold.

KeyBank National Association first reported a position in BLUE in Q2 2022 and held it in 2 quarters. The position peaked at $65K in Q3 2022. 184 funds tracked by Wall St. Rank hold BLUE as of Q4 2022.

  • KeyBank National Association reported no remaining bluebird bio position as of Q4 2022 after selling out during the quarter.
  • KeyBank National Association sold 512 bluebird bio shares in Q4 2022, an estimated $65K.
  • KeyBank National Association first reported a position in bluebird bio in Q2 2022 and held it in 2 quarters.
  • KeyBank National Association's bluebird bio position peaked at $65K in Q3 2022.
  • 184 funds tracked by Wall St. Rank held bluebird bio as of Q4 2022.

Based on KeyBank National Association's 13F filing for Q4 2022, filed 31 Jan 2023.